Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The E6 protein is an oncoprotein encoded by the high-risk human papillomavirus type 16 (HPV-16), a major causative agent of cervical cancer and other HPV-associated malignancies. It plays a central role in the induction and maintenance of cellular transformation, enabling viral replication, cell immortalization, and evasion of host immune responses. E6 acts primarily through targeting the tumor suppressor p53 for degradation, upregulating telomerase activity, and inhibiting apoptosis and immune responses.
Targets tumor suppressor proteins (p53, MAGI-1, SAP97/hDlg, DLG1, NFX1, BAK1, FADD, procaspase 8) for degradation; activates telomerase; inhibits interferon signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Type 16 E6 Protein (HPV16 E6).